Stanford Heme Group — Palo Alto, California

Stanford Heme Group is a clinical research site located in Palo Alto, California, United States.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford Heme Group has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma.

Sponsors: Cephalon.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Heme Group?

Stanford Heme Group has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Heme Group conducted?

Stanford Heme Group has 1 clinical trials on record. Their work covers Multiple Myeloma.

Is Stanford Heme Group accredited by Crixeo Health?

Stanford Heme Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Heme Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.